MARIZYME, INC.: key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2023)
- $645.8K
- Net Income/Loss (FY2023)
- -$69.5M
- Total Assets (FY2023)
- $22.0M
- Total Equity (FY2023)
- -$6.7M
- Cash Flows from Operating Activities (FY2023)
- -$4.7M
Source: MARIZYME, INC. 10-K/A filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
